Last updated on February 2018

French Registry of First-line Treatment of Acute Promyelocytic Leukemia


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Acute Promyelocytic Leukemia
  • Age: - 70 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Newly-diagnosed APL (either de novo or therapy-related) based on cytologic criteria and confirmed by the presence of the t(15;17) translocation and/or by the detection of the fusion transcript PML/RAR.
  • Non-high-risk APL (White Blood Count < 10000/l at presentation)
  • Age 70 years

Exclusion Criteria:

  • Relapsed APL
  • Newly-diagnosed High-risk APL (White Blood Count > 10000/l at presentation)
  • Age > 70 years

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.